Torrent Pharmaceuticals Limited
Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals
Key metrics
Price as of 2026-07-17
Stock price
₹4763.00
Market cap
1,61,176 Cr
Stock P/E
73.9
P/B
9.17
Dividend yield
0.8%
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,591 Cr | 2,660 Cr | 2,732 Cr | 2,745 Cr | 2,859 Cr | 2,889 Cr | 2,809 Cr | 2,959 Cr | 3,178 Cr | 3,302 Cr | 3,303 Cr | 4,197 Cr |
| Operating expenses (approx.) | 1,766 Cr | 1,809 Cr | 1,808 Cr | 1,831 Cr | 1,931 Cr | 1,966 Cr | 1,895 Cr | 2,037 Cr | 2,183 Cr | 2,259 Cr | 2,225 Cr | 2,924 Cr |
| EBITDA | 825 Cr | 851 Cr | 924 Cr | 914 Cr | 928 Cr | 923 Cr | 914 Cr | 922 Cr | 995 Cr | 1,043 Cr | 1,078 Cr | 1,273 Cr |
| OPM % | 31.8% | 32.0% | 33.8% | 33.3% | 32.5% | 31.9% | 32.5% | 31.2% | 31.3% | 31.6% | 32.6% | 30.3% |
| Other income | 34 Cr | 26 Cr | -33 Cr | 31 Cr | 24 Cr | -16 Cr | 33 Cr | -18 Cr | -37 Cr | -27 Cr | -13 Cr | -17 Cr |
| Interest | 103 Cr | 91 Cr | 80 Cr | 80 Cr | 75 Cr | 64 Cr | 57 Cr | 56 Cr | 56 Cr | 48 Cr | 45 Cr | 236 Cr |
| Depreciation | 191 Cr | 201 Cr | 213 Cr | 203 Cr | 197 Cr | 198 Cr | 199 Cr | 201 Cr | 201 Cr | 204 Cr | 206 Cr | 508 Cr |
| Profit before tax | 531 Cr | 559 Cr | 631 Cr | 631 Cr | 656 Cr | 661 Cr | 691 Cr | 665 Cr | 738 Cr | 791 Cr | 814 Cr | 529 Cr |
| Tax % | 28.8% | 30.9% | 29.8% | 28.8% | 30.3% | 31.5% | 27.2% | 25.1% | 25.7% | 25.3% | 22.0% | 31.2% |
| Net profit | 378 Cr | 386 Cr | 443 Cr | 449 Cr | 457 Cr | 453 Cr | 503 Cr | 498 Cr | 548 Cr | 591 Cr | 635 Cr | 364 Cr |
| EPS (₹) | ₹11.18 | ₹11.39 | ₹13.10 | ₹13.27 | ₹13.51 | ₹13.37 | ₹14.88 | ₹14.71 | ₹16.19 | ₹17.45 | ₹18.77 | ₹11.51 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 7,673 Cr | 7,939 Cr | 8,005 Cr | 8,508 Cr | 9,620 Cr | 10,728 Cr | 11,516 Cr | 13,980 Cr | Sign in for TTM |
| Operating expenses (approx.) | 5,989 Cr | 5,647 Cr | 5,463 Cr | 6,365 Cr | 6,778 Cr | 7,272 Cr | 7,796 Cr | 9,604 Cr | Sign in for TTM |
| EBITDA | 1,684 Cr | 2,292 Cr | 2,542 Cr | 2,143 Cr | 2,842 Cr | 3,456 Cr | 3,720 Cr | 4,376 Cr | Sign in for TTM |
| OPM % | 21.9% | 28.9% | 31.8% | 25.2% | 29.5% | 32.2% | 32.3% | 31.3% | Sign in for TTM |
| Other income | 57 Cr | 122 Cr | 57 Cr | 197 Cr | 45 Cr | 58 Cr | 23 Cr | -94 Cr | Sign in for TTM |
| Interest | 504 Cr | 451 Cr | 358 Cr | 255 Cr | 333 Cr | 354 Cr | 252 Cr | 385 Cr | Sign in for TTM |
| Depreciation | 618 Cr | 654 Cr | 658 Cr | 662 Cr | 707 Cr | 808 Cr | 795 Cr | 1,119 Cr | Sign in for TTM |
| Profit before tax | 562 Cr | 1,187 Cr | 1,526 Cr | 1,226 Cr | 1,847 Cr | 2,352 Cr | 2,673 Cr | 2,872 Cr | Sign in for TTM |
| Tax % | 22.4% | 13.6% | 18.0% | 36.6% | 32.6% | 29.6% | 28.5% | 25.6% | Sign in for TTM |
| Net profit | 436 Cr | 1,025 Cr | 1,252 Cr | 777 Cr | 1,245 Cr | 1,656 Cr | 1,911 Cr | 2,138 Cr | Sign in for TTM |
| EPS (₹) | ₹25.78 | ₹60.55 | ₹73.98 | ₹45.93 | ₹36.79 | ₹48.94 | ₹56.47 | ₹63.92 | Sign in for TTM |
| Dividend payout % | — | — | — | 87.1% | 69.3% | 61.3% | 56.7% | 60.3% | Sign in for TTM |
Sign in for TTM
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 85 Cr | 85 Cr | 85 Cr | 85 Cr | 169 Cr | 169 Cr | 169 Cr | 169 Cr |
| Reserves | 4,639 Cr | 4,739 Cr | 5,753 Cr | 5,868 Cr | 6,029 Cr | 6,687 Cr | 7,422 Cr | 8,220 Cr |
| Borrowings | — | — | — | — | 5,297 Cr | 3,938 Cr | 1,834 Cr | 3,147 Cr |
| Other liabilities | — | — | — | — | 3,517 Cr | 4,267 Cr | 5,565 Cr | 23,580 Cr |
| Total liabilities | — | — | — | — | 15,012 Cr | 15,061 Cr | 14,990 Cr | 44,312 Cr |
| Fixed assets (net) | — | — | — | — | 2,772 Cr | 3,297 Cr | 3,455 Cr | 4,909 Cr |
| CWIP | — | — | — | — | 688 Cr | 281 Cr | 367 Cr | 457 Cr |
| Investments | — | — | — | — | 199 Cr | 173 Cr | 156 Cr | 949 Cr |
| Other assets | — | — | — | — | 5,316 Cr | 5,614 Cr | 5,628 Cr | 9,397 Cr |
| Total assets | — | — | — | — | 15,012 Cr | 15,061 Cr | 14,990 Cr | 44,312 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | — | — | — | 1,803 Cr | 2,368 Cr | 3,266 Cr | 2,585 Cr | 3,023 Cr |
| Cash from investing | — | — | — | -198 Cr | -2,356 Cr | -168 Cr | -540 Cr | -12,713 Cr |
| Cash from financing | — | — | — | -1,781 Cr | 77 Cr | -2,779 Cr | -2,298 Cr | 10,151 Cr |
| Net cash flow | — | — | — | -176 Cr | 89 Cr | 319 Cr | -253 Cr | 461 Cr |
| Free cash flow (OCF − Capex) | — | — | — | 1,600 Cr | 1,794 Cr | 2,833 Cr | 1,974 Cr | 2,346 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| ROCE % | 22.6% | 34.0% | 32.3% | 24.9% | 18.6% | 24.5% | 31.0% | 15.7% |
| ROE % | 9.2% | 21.2% | 21.4% | 13.1% | 20.1% | 24.2% | 25.2% | 12.3% |
| Debtor days | — | — | — | — | 74 | 63 | — | — |
| Inventory days | — | — | — | — | 548 | 502 | 609 | 650 |
| Days payable | — | — | — | — | 413 | 460 | — | — |
| Cash conversion cycle | — | — | — | — | 209 | 105 | 609 | 650 |
| Debt / equity | — | — | — | — | 0.85 | 0.57 | 0.24 | 0.18 |
| Current ratio | — | — | — | — | 0.98 | 1.03 | 1.19 | 1.13 |
| Net debt / EBITDA | 0.00 | 0.00 | 0.00 | 0.00 | 1.69 | 0.90 | 0.34 | 0.46 |
Compare with peers
Loading peers…